Join the watch

Amgen, Inc.

$188.25
AMGN - NASDAQ
Dividend yield
-
Payout ratio
-
P/E (12m)
-
EPS
-
Amgen, Inc. description

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K.

Bowes, Jr., Franklin Pitcher Johnson, Jr., George B.

Company profile
Market cap
Mega (111.03B)
Company CEO
Robert A. Bradway
AMGN dividends payouts